NORTH AMERICA APHERESIS MARKET FORECAST 2021-2028

The North America apheresis market is expected to register a CAGR of 8.12% during the forecast period, 2021 to 2028. The rising number of apheresis procedures, the access to well-developed healthcare infrastructure, and the increasing rates of plasma exchange procedures are among the key factors associated with the region’s market growth.

north-america-apheresis-market

The North America apheresis market growth analysis includes the study of the United States and Canada. Apheresis is characterized as a medical procedure involving the removal of the whole blood from a patient or donor. The blood is then separated into individual components in order to remove a particular constituent. Subsequently, the remaining blood components are re-introduced into the patient or donor bloodstream.

According to the National Clinical Trial Registry, as of June 2020, the United States has nearly 53 ongoing clinical trials associated with apheresis. The trials involve different indications across various phases of development within the country. Conversely, the rapid surge in COVID-19 cases is set to fuel the market demand, since the apheresis technique is extensively used to treat infected patients as a plasma therapy. Hence, the aforementioned factors, in addition to the rising focus on treating various conditions through the apheresis technique, are set to fuel the market growth in the United States over the forecast years.

Haemonetics Corporation, headquartered in the United States, is an international healthcare company committed to providing a comprehensive range of innovative hematology products and solutions. It delivers a diversified product portfolio of devices, information management, and consulting services for blood management solutions across the blood supply chain. With a global presence, the company’s products are distributed across the world, from its top distributor centers in Switzerland and Tennessee.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. PREVAILING INCIDENCE OF HEMATOLOGIC DISEASES
      2. ADVANCEMENT IN TECHNOLOGIES OF APHERESIS TECHNIQUE
      3. FAVORABLE REIMBURSEMENT POLICIES AND FUNDING FOR APHERESIS PROCEDURES
      4. GROWING GERIATRIC POPULATION
    2. KEY RESTRAINTS
      1. RISK OF BLOOD CONTAMINATION WHILE CONDUCTING TRANSFUSIONS
      2. HIGH COST OF INVESTMENT ASSOCIATED WITH APHERESIS PROCEDURES
  4. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON APHERESIS MARKET
    2. KEY MARKET TRENDS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRY
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
  5. MARKET BY PROCEDURE
    1. PLASMAPHERESIS
    2. PLATELETPHERESIS
    3. LEUKAPHERESIS
    4. ERYTHROCYTAPHERESIS
    5. OTHER APHERESIS PROCEDURES
  6. MARKET BY TECHNOLOGY
    1. CENTRIFUGATION
    2. MEMBRANE SEPARATION
  7. MARKET BY PRODUCT
    1. DISPOSABLE APHERESIS KITS
    2. APHERESIS MACHINE
  8. MARKET BY APPLICATION
    1. HEMATOLOGICAL DISORDERS
    2. NEUROLOGICAL DISORDERS
    3. AUTOIMMUNE DISORDERS
    4. RENAL DISORDERS
    5. OTHER APPLICATIONS
  9. MARKET BY END-USER
    1. BLOOD BANKS/ BLOOD DONATION CENTERS
    2. HOSPITALS & CLINICS
    3. AMBULATORY SURGICAL CENTERS
  10. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. UNITED STATES
        2. CANADA
  11. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
    2. COMPANY PROFILES
      1. ASAHI KASEI CORPORATION
      2. BAXTER INTERNATIONAL INC
      3. B BRAUN MELSUNGEN AG
      4. CERUS CORPORATION
      5. CYTOSORBENTS CORPORATION
      6. FRESENIUS SE & CO KGAA (FRESENIUS KABI AG)
      7. HAEMONETICS CORPORATION
      8. HEMACARE CORPORATION
      9. INFOMED
      10. KANEKA CORPORATION
      11. KAWASUMI LABORATORIES INC
      12. MEDICAP CLINIC GMBH
      13. MEDICA SPA
      14. MILTENYI BIOTEC
      15. TERUMO CORPORATION (TERUMO BCT)
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - APHERESIS

TABLE 2: NORTH AMERICA APHERESIS MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: NORTH AMERICA APHERESIS MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: NORTH AMERICA APHERESIS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: NORTH AMERICA APHERESIS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: NORTH AMERICA APHERESIS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: NORTH AMERICA APHERESIS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: NORTH AMERICA APHERESIS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: NORTH AMERICA APHERESIS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: NORTH AMERICA APHERESIS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: NORTH AMERICA APHERESIS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: NORTH AMERICA APHERESIS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: NORTH AMERICA APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: LEADING PLAYERS OPERATING IN NORTH AMERICA APHERESIS MARKET

TABLE 15: LIST OF MERGERS & ACQUISITIONS

TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 18: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: NORTH AMERICA APHERESIS MARKET, BY PROCEDURE, IN 2020

FIGURE 6: NORTH AMERICA APHERESIS MARKET, BY PLASMAPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 7: NORTH AMERICA APHERESIS MARKET, BY PLATELETPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 8: NORTH AMERICA APHERESIS MARKET, BY LEUKAPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA APHERESIS MARKET, BY ERYTHROCYTAPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA APHERESIS MARKET, BY OTHER APHERESIS PROCEDURES, 2021-2028 (IN $ MILLION)

FIGURE 11: NORTH AMERICA APHERESIS MARKET, BY TECHNOLOGY, IN 2020

FIGURE 12: NORTH AMERICA APHERESIS MARKET, BY CENTRIFUGATION, 2021-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA APHERESIS MARKET, BY MEMBRANE SEPARATION, 2021-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA APHERESIS MARKET, BY PRODUCT, IN 2020

FIGURE 15: NORTH AMERICA APHERESIS MARKET, BY DISPOSABLE APHERESIS KITS, 2021-2028 (IN $ MILLION)

FIGURE 16: NORTH AMERICA APHERESIS MARKET, BY APHERESIS MACHINE, 2021-2028 (IN $ MILLION)

FIGURE 17: NORTH AMERICA APHERESIS MARKET, BY APPLICATION, IN 2020

FIGURE 18: NORTH AMERICA APHERESIS MARKET, BY HEMATOLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 19: PREVALENCE OF BLEEDING DISORDER IN NORTH AMERICA, 2019

FIGURE 20: NORTH AMERICA APHERESIS MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 21: NORTH AMERICA APHERESIS MARKET, BY AUTOIMMUNE DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 22: NORTH AMERICA APHERESIS MARKET, BY RENAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 23: NORTH AMERICA APHERESIS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 24: NORTH AMERICA APHERESIS MARKET, BY END-USER, IN 2020

FIGURE 25: NORTH AMERICA APHERESIS MARKET, BY BLOOD BANKS/ BLOOD DONATION CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 26: NORTH AMERICA APHERESIS MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 27: NORTH AMERICA APHERESIS MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 28: NORTH AMERICA APHERESIS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 29: UNITED STATES APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: CANADA APHERESIS MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample